Q2 2023 Hansa Biopharma AB Earnings Call Transcript
Good afternoon, and welcome to the Hansa Biopharma Quarter 2 2023 Conference Call. My name is Carla, and I will be the operator for today's call. (Operator Instructions)
I would now like to pass the conference over to our host, Søren Tulstrup to begin. Please go ahead when you're ready.
¸ - ()-&
Thank you, operator. Good morning, good afternoon, and welcome to the Hansa Biopharma conference call to review second quarter 2023 results. I'm Søren Tulstrup, CEO of Hansa Biopharma. Joining me today is our Chief Commercial Officer and newest President, Matt Shaulis, and our CFO, Donato Spota; our Head of Investor Relations, Klaus Sindahl, is also with us.
Today, we'll discuss the highlights and progress we made during the second quarter of 2023 and review our near-term milestones. The presentation should take roughly 20 minutes, after which there will be an opportunity to ask questions during the Q&A session.
Please
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |